Establishment unit data
In general | |||
| Enterprise number: | 0508.634.049 | ||
| Status of the entity: | Active | ||
| Number of the establishment unit: | 2.215.063.294 | ||
| Status of the establishment unit: | Active | ||
| Start date: | January 1, 2013 | ||
| Name of the establishment unit: |
APOTHEEK CAUWENBERGH WOLVERTEM Name in Dutch, since January 3, 2013 | ||
| Address of the establishment unit: |
Hoogstraat 8
1861 Meise Since November 1, 2017 | ||
| Phone number: | No information found in the CBE. | ||
| Fax: | No information found in the CBE. | ||
| Email address: | No information found in the CBE. | ||
| Web address: | No information found in the CBE. | ||
| | |||
Authorisations | |||
| Licences registered with the Federal Agency for the Safety of the Food Chain (FASFC) Click here | |||
| | |||
Version of Nacebel codes for activities 2008(1) | |||
| Main activity: 47.730
- Retail trade of pharmaceutical products in specialised stores Since January 3, 2013 | |||
| Additional activity: 10.860
- Manufacture of homogenised food preparations and dietetic food Since January 3, 2013 | |||
| Additional activity: 10.86001
- Manufacture of foodstuffs for particular nutritional uses: preparations for infants, follow-up milk and other foods given to older infants, baby food, etc. Since January 3, 2013 | |||
| Additional activity: 20.140
- Manufacture of other organic basic chemicals Since January 3, 2013 | |||
| Additional activity: 21.100
- Manufacture of basic pharmaceutical products Since January 3, 2013 | |||
| Additional activity: 21.10001
- Study, development of the production of active ingredients for drug manufacturing Since January 3, 2013 | |||
| Additional activity: 21.10002
- Production of salicylic and o-acetylsalicylic acid Since January 3, 2013 | |||
| Additional activity: 21.10003
- Processing of blood Since January 3, 2013 | |||
| Additional activity: 21.10004
- Processing of glands and manufacture of extracts of glands, etc. Since January 3, 2013 | |||
| Additional activity: 21.201
- Manufacture of medicaments Since January 3, 2013 | |||
| Additional activity: 21.20101
- Manufacture of diverse medicaments, including homeopathic preparations Since January 3, 2013 | |||
| Additional activity: 21.20102
- Manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments Since January 3, 2013 | |||
| Additional activity: 21.20103
- Manufacture of veterinary preparations Since January 3, 2013 | |||
| Additional activity: 21.20104
- Manufacture of herbal teas from medicinal plants Since January 3, 2013 | |||
| Additional activity: 21.209
- Manufacture of other pharmaceutical products Since January 3, 2013 | |||
| Additional activity: 47.74002
- Retail trade of herbalist products Since January 3, 2013 | |||
| Additional activity: 47.75001
- Retail trade of perfume and cosmetics Since January 3, 2013 | |||
| Additional activity: 47.75002
- Retail trade of toiletries Since January 3, 2013 | |||
| | |||
Version of the Nacebel codes for the NSSO-activities 2008(1) | |||
| Main activity: 47.730
- Retail trade of pharmaceutical products in specialised stores Since January 3, 2013 | |||
| | |||
Version of the Nacebel codes for the NSSO-activities 2025(1) | |||
| Main activity: 47.730
- Retail sale of pharmaceutical products Since January 1, 2025 | |||
| | ||
| No data included in CBE. |
(1)Activities are registered in the CBE using NACE-BEL codes (Belgian classification of activities). There are different versions of these codes. Activities with a NACE-BEL code (version 2003) were stopped on 31/12/2007 and automatically converted to the new NACE-BEL codes (2008 version) starting on 01/01/2008. A new 2025 version of the codes will enter into force on 01/01/2025. During the first half of the year 2025, all activities with a 2008 version of the NACE-BEL code will be phased out with 31/12/2024 as end date and automatically converted to the 2025 version of the NACE-BEL codes, starting on 01/01/2025. Up until then, activities will continue to be registered using the 2008 NACE-BEL codes.
